Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) Invested Capital (2023 - 2025)

Camp4 Therapeutics' Invested Capital history spans 3 years, with the latest figure at $47.7 million for Q4 2025.

  • For Q4 2025, Invested Capital fell 24.45% year-over-year to $47.7 million; the TTM value through Dec 2025 reached $47.7 million, down 24.45%, while the annual FY2025 figure was $47.7 million, 24.45% down from the prior year.
  • Invested Capital for Q4 2025 was $47.7 million at Camp4 Therapeutics, down from $58.7 million in the prior quarter.
  • Across five years, Invested Capital topped out at $63.1 million in Q4 2024 and bottomed at -$159.0 million in Q3 2024.
  • The 3-year median for Invested Capital is -$35.7 million (2023), against an average of -$41.5 million.
  • The largest YoY upside for Invested Capital was 151.03% in 2024 against a maximum downside of 42.51% in 2024.
  • A 3-year view of Invested Capital shows it stood at -$123.7 million in 2023, then skyrocketed by 151.03% to $63.1 million in 2024, then decreased by 24.45% to $47.7 million in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Invested Capital are $47.7 million (Q4 2025), $58.7 million (Q3 2025), and $40.1 million (Q2 2025).